Reduction of A1c with Dulaglutide in Type 2 Diabetes (T2D) Patients Positive or Negative for GAD Antibodies (GADA): A Post-hoc Analysis of AWARD-2,-4, and-5
dc.contributor.author | Pozzilli, P | en_US |
dc.contributor.author | Leslie, RD | en_US |
dc.contributor.author | Peters, A | en_US |
dc.contributor.author | Buzzetti, R | en_US |
dc.contributor.author | Milicevic, Z | en_US |
dc.contributor.author | Pavo, I | en_US |
dc.contributor.author | Lebrec, J | en_US |
dc.contributor.author | Martin, S | en_US |
dc.contributor.author | Schloot, N | en_US |
dc.date.accessioned | 2020-10-22T15:54:00Z | |
dc.date.issued | 2017-06-01 | en_US |
dc.identifier.issn | 0012-1797 | en_US |
dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/67719 | |
dc.format.extent | A287 - A287 | en_US |
dc.title | Reduction of A1c with Dulaglutide in Type 2 Diabetes (T2D) Patients Positive or Negative for GAD Antibodies (GADA): A Post-hoc Analysis of AWARD-2,-4, and-5 | en_US |
dc.type | Conference Proceeding | |
pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000408064102193&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 66 | en_US |
Files in this item
This item appears in the following Collection(s)
-
Centre for Immunobiology [1121]